Boothbay Fund Management’s Amgen AMGN Stock Holding History

Boothbay Fund Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-66,000	Closed	-$21.6M	–	2033
2025 Q4	$21.6M	Buy	+66,000	New	+$20.9M	0.32%	37
2022 Q3	–	Sell	-1,300	Closed	-$316K	–	2217
2022 Q2	$316K	Sell	1,300 -1,600	-55%	-$392K	0.01%	1434
2022 Q1	$701K	Buy	+2,900	New	+$666K	0.02%	1117
2019 Q2	–	Sell	-397	Closed	-$7.54M	–	721
2019 Q1	$7.54M	Buy	+397	New	+$75.8K	0.73%	20

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Boothbay Fund Management's AMGN Position: Q2 2026 in Review

Boothbay Fund Management reduced its Amgen (AMGN) stake by 35% in Q2 2026, selling an estimated $208K and leaving 1,148 shares worth $416K. The position accounts for 0.01% of the portfolio, ranked #1610.

Boothbay Fund Management first reported a position in AMGN in Q3 2015 and has held it in 16 quarters since. The position peaked at $4.92M in Q4 2025. 3,150 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Boothbay Fund Management held 1,148 shares of Amgen worth $416K as of Q2 2026.
Boothbay Fund Management sold 607 Amgen shares in Q2 2026, an estimated $208K.
Amgen made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1610 holding.
Boothbay Fund Management first reported a position in Amgen in Q3 2015 and has held it in 16 quarters since.
Boothbay Fund Management's Amgen position peaked at $4.92M in Q4 2025.
3,150 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.